Learn more about whether Open Text Corporation or Vertex, Inc. is a better investment based on AAII's A+ Investor grades, ...

Morgan Stanley raised the firm’s price target on Vertex (VERX) to $60 from $57 and keeps an Overweight rating on the shares. The company’s ...

There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Vertex (VERX – Research Report) and AppLovin ...

The Israeli spyware company blacklisted over human rights concerns has hired the firm to provide strategic advice on cyber policy issues.

Nonprofit organizations utilizing the latest ezCheckprinting and virtual printer software no longer need be concerned about ...

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

TIARA 2025, the two-day techno cultural fest organized by St Joseph Engineering College (SJEC), Mangaluru, was inaugurated on ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $503.20, representing a -1.37% change from its previous close. Amicus Therapeutics (FOLD) reported earnings 30 days ago.

It is hard to get excited after looking at Arista Networks' (NYSE:ANET) recent performance, when its stock has declined... Investors may develop a bias toward prior market leaders, giving them ...

Juniper Networks (NYSE: JNPR), a leader in secure, AI-Native Networking, today announced a new solution purpose-built for neocloud, traditional SPs and other AI cloud providers who are deploying ...

A gene regulatory network is a set of genes, or parts of genes, that interact with each other to control a specific cell function. Gene regulatory networks are important in development ...